These provide reference points for comparison
They are not intended to represent clinical evidence in humans, and BPC-157 has not been approved by the FDA, EMA, or any other regulatory authority for any indication
Documenting your microdose-to-standard transition is valuable for two reasons
Since glutathione fights off toxins, it reduces or rids the body of oxidative stress and fights disease (3)
GLP1 also decreases both the release and breakdown of stored carbohydrates as well as the synthesis of new glucose by inhibiting the production of glucagon which is a hormone responsible for increasing glucose levels in the body
A study published in the European Journal of Clinical Investigation found that glutathione supplementation can improve immune response in individuals with deficiencies, as well as in older people, whose immune function tends to decline with age